Table 2. Development of End-Stage Renal Disease in Subgroups of Live Kidney Donors in the United States, 1994-2011.
No. of Donors | Cases of ESRD | Cumulative Incidence of ESRD at 15 Years per 10 000 (95% CI) | |
---|---|---|---|
All donorsa | 96 217 | 99 | 30.8 (24.3-38.5) |
Age at donation, y | |||
18-39 | 46 344 | 50 | 29.4 (21.4-40.2) |
40-49 | 28 994 | 17 | 17.4 (10.1-30.0) |
50-59 | 16 840 | 25 | 54.6 (34.8-85.4) |
≥60 | 4039 | 7 | 70.2 (30.4-161.8) |
Sex | |||
Women | 56 775 | 42 | 21.1 (14.9-29.9) |
Men | 39 442 | 57 | 44.1 (32.9-59.1) |
Race | |||
White/other | 71 769 | 50 | 22.7 (15.6-30.1) |
Black | 12 387 | 36 | 74.7 (47.8-105.8) |
Hispanic | 12 061 | 13 | 32.6 (17.9-59.1) |
Relationship to recipientb | |||
Biological | 64 897 | 83 | 34.1 (26.9-43.3) |
Nonbiological | 31 081 | 16 | 15.1 (08.7-26.3) |
In a mean (SD) of 8.6 (3.6) years after donation, 99 donors who were aged 50 (13) years developed end-stage renal disease (ESRD).
Relationship to recipient was missing for 0.25% of the records between 1994-2011.